DEFINITIVE PROXY STATEMENT

Company

INTEGRATED BIOPHARMA INC

Filed

January 13, 2003

Period of Report

November 27, 2002

Accession Number

0001169232-03-000185

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →